AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
8.30
0.00 (0.00%)
At close: Jun 18, 2025, 4:00 PM
8.30
0.00 (0.00%)
Pre-market: Jun 20, 2025, 7:47 AM EDT
AIM ImmunoTech Employees
As of December 31, 2024, AIM ImmunoTech had 23 total employees, including 21 full-time and 2 part-time employees. The number of employees decreased by 5 or -17.86% compared to the previous year.
Employees
23
Change (1Y)
-5
Growth (1Y)
-17.86%
Revenue / Employee
$6,348
Profits / Employee
-$661,217
Market Cap
6.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
AIM News
- 2 days ago - AIM ImmunoTech Resumes Trading on NYSE American - GlobeNewsWire
- 7 days ago - AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen® - GlobeNewsWire
- 8 days ago - AIM ImmunoTech Announces NYSE American Removal of Trading Suspension - GlobeNewsWire
- 8 days ago - AIM ImmunoTech Announces 1-for-100 Reverse Stock Split - GlobeNewsWire
- 5 weeks ago - Aimia Inc. (AIMFF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists - GlobeNewsWire
- 2 months ago - AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market - GlobeNewsWire
- 2 months ago - AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal - GlobeNewsWire